On-label prescribing of Wegovy (use among people with overweight or obesity) increased sharply in December 2022, after a months-long drug shortage of the drug ended (Today, 2023)
Fill out the form below to get started
Is the increased risk significant
The daily pill, available with a prescription, generally costs less than the weekly injection for self-pay patients willing to buy directly from Novo Nordisk and forgo insurance
Similar content being viewed by others Subjects Introduction Hepatic steatosis, characterized by excessive accumulation of triglycerides (TGs) in hepatocytes, is considered the cause of nonalcoholic fatty liver disease (NAFLD) 1,2,3
What the FDA's Rule Means for Compounded GLP-1 Access Will the rule mean that all access to compounded versions of GLP-1s will go away